Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. Operating Income 2021–2025
Gyre Therapeutics Inc. annual/quarterly operating income history and growth rate from 2021 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Gyre Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -6.8 M, a 399.25% decrease year-over-year.
- Gyre Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was 2.4 M.
- Gyre Therapeutics Inc. annual operating income for 2025 was 11.5 M, a 29.19% decrease from 2024.
- Gyre Therapeutics Inc. annual operating income for 2024 was 16.2 M, a 15.53% decrease from 2023.
- Gyre Therapeutics Inc. annual operating income for 2023 was 19.2 M, a 1420.62% increase from 2022.
- Gyre Therapeutics Inc. annual operating income for 2022 was 1.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gyre Therapeutics Inc. Operating Income — FAQ
Gyre Therapeutics Inc. (GYRE) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Gyre Therapeutics Inc.'s operating income?
Gyre Therapeutics Inc. (GYRE) reported operating income of $11M for fiscal 2025.
Where can I see GYRE's operating income history?
The chart and table above show Gyre Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.